These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12513829)

  • 1. [Expression and function of CD95/fas antigen and Bcl-2 on cord blood hematopoietic progenitor cells].
    Ma YP; Zhou P; Xiao J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):13-6. PubMed ID: 12513829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver.
    Bárcena A; Park SW; Banapour B; Muench MO; Mechetner E
    Blood; 1996 Sep; 88(6):2013-25. PubMed ID: 8822920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional expression of CD95/Fas antigen and Bcl-2 on cord blood hematopoietic progenitor cells.
    Ma Y; Zou P
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(1):24-7. PubMed ID: 12658775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of Fas and bcl-2 expression in hematopoietic precursors.
    Maurillo L; Del Poeta G; Venditti A; Buccisano F; Battaglia A; Santinelli S; Caravita T; Epiceno AM; Del Moro B; Tamburini A; Picardi A; Suppo G; Catalano G; Bruno A; Amadori S
    Haematologica; 2001 Mar; 86(3):237-43. PubMed ID: 11255269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of interferon-gamma and tumor necrosis factor-alpha on CD34+ bone marrow progenitor cells from aplastic anemia patients and normal donors.
    Welsh JP; Rutherford TR; Flynn J; Foukaneli T; Gordon-Smith EC; Gibson FM
    Hematol J; 2004; 5(1):39-46. PubMed ID: 14745429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fas antigen expression on human hematopoietic progenitor cells].
    Nagafuji K; Takenaka K; Niho Y
    Nihon Rinsho; 1996 Jul; 54(7):1790-6. PubMed ID: 8741668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells.
    Nagafuji K; Shibuya T; Harada M; Mizuno S; Takenaka K; Miyamoto T; Okamura T; Gondo H; Niho Y
    Blood; 1995 Aug; 86(3):883-9. PubMed ID: 7542501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis.
    Kim H; Whartenby KA; Georgantas RW; Wingard J; Civin CI
    Stem Cells; 2002; 20(2):174-82. PubMed ID: 11897874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of apoptosis in cryoinjury of cord blood hematopoietic stem/progenitor cells and its mechanism].
    Xiao J; Zou P; Huang SA; Hu ZB; Liu LB; You Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Feb; 12(1):90-4. PubMed ID: 14989778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas antigen (CD95) and hematopoietic progenitor cells.
    Nagafuji K; Takenaka K; Shibuya T; Harada M; Niho Y
    Leuk Lymphoma; 1996 Dec; 24(1-2):43-56. PubMed ID: 9049961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of interleukin-1beta-converting enzyme in human hematopoietic progenitor cells results in blockade of cytokine-mediated apoptosis and expansion of their proliferative potential.
    Sloand EM; Young NS; Sato T; Kim S; Maciejewski JP
    Exp Hematol; 1998 Oct; 26(11):1093-9. PubMed ID: 9766451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro.
    Maciejewski J; Selleri C; Anderson S; Young NS
    Blood; 1995 Jun; 85(11):3183-90. PubMed ID: 7538820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reduction of in vitro radiation-induced Fas-related apoptosis in CD34+ progenitor cells by SCF, FLT-3 ligand, TPO, and IL-3 in combination resulted in CD34+ cell proliferation and differentiation.
    Drouet M; Mathieu J; Grenier N; Multon E; Sotto JJ; Herodin F
    Stem Cells; 1999; 17(5):273-85. PubMed ID: 10527462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of the serum panel reactive antibody on proliferation and differentiation of cord blood CD34+ cells in vitro].
    Yang XG; Fang JP; Wu YF; Weng WJ; Xu HG; Xu LH
    Zhonghua Er Ke Za Zhi; 2008 Nov; 46(11):831-5. PubMed ID: 19099900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of Fas-mediated apoptosis of murine granulosa cells by interferon-gamma, tumor necrosis factor-alpha, and cycloheximide.
    Quirk SM; Porter DA; Huber SC; Cowan RG
    Endocrinology; 1998 Dec; 139(12):4860-9. PubMed ID: 9832422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and modulation of cellular receptors for interferon-gamma, tumour necrosis factor, and Fas on human bone marrow CD34+ cells.
    Sato T; Selleri C; Anderson S; Young NS; Maciejewski JP
    Br J Haematol; 1997 May; 97(2):356-65. PubMed ID: 9163602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells.
    Josefsen D; Myklebust JH; Lømo J; Sioud M; Blomhoff HK; Smeland EB
    Stem Cells; 2000; 18(4):261-72. PubMed ID: 10924092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of anti-TGF-beta antibody on ex vivo expansion and expression of adhesion molecules of human cord blood CD34+ cells].
    Qian J; Liu FQ; Wu YP; Wang Y; Kang WT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):664-8. PubMed ID: 16129056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD95 (APO-1/FAS)-mediated apoptosis in cytokine-activated hematopoietic cells.
    Stahnke K; Hecker S; Kohne E; Debatin KM
    Exp Hematol; 1998 Aug; 26(9):844-50. PubMed ID: 9694505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis.
    Hinz S; Trauzold A; Boenicke L; Sandberg C; Beckmann S; Bayer E; Walczak H; Kalthoff H; Ungefroren H
    Oncogene; 2000 Nov; 19(48):5477-86. PubMed ID: 11114725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.